These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25595783)

  • 1. Elevation of c-MYC disrupts HLA class II-mediated immune recognition of human B cell tumors.
    God JM; Cameron C; Figueroa J; Amria S; Hossain A; Kempkes B; Bornkamm GW; Stuart RK; Blum JS; Haque A
    J Immunol; 2015 Feb; 194(4):1434-45. PubMed ID: 25595783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma.
    Goldstein OG; Hajiaghamohseni LM; Amria S; Sundaram K; Reddy SV; Haque A
    Cancer Immunol Immunother; 2008 Oct; 57(10):1461-70. PubMed ID: 18343923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47,000 MW acid labile protein in CD4+ T-cell recognition.
    God JM; Zhao D; Cameron CA; Amria S; Bethard JR; Haque A
    Immunology; 2014 Jul; 142(3):492-505. PubMed ID: 24628049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms regulating enhanced human leukocyte antigen class II-mediated CD4 + T cell recognition of human B-cell lymphoma by resveratrol.
    Radwan FF; Zhang L; Hossain A; Doonan BP; God JM; Haque A
    Leuk Lymphoma; 2012 Feb; 53(2):305-14. PubMed ID: 21854084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class II defects in Burkitt lymphoma: bryostatin-1-induced 17 kDa protein restores CD4+ T-cell recognition.
    Hossain A; God JM; Radwan FF; Amria S; Zhao D; Bethard JR; Haque A
    Clin Dev Immunol; 2011; 2011():780839. PubMed ID: 22162713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-myc activation impairs the NF-kappaB and the interferon response: implications for the pathogenesis of Burkitt's lymphoma.
    Schlee M; Hölzel M; Bernard S; Mailhammer R; Schuhmacher M; Reschke J; Eick D; Marinkovic D; Wirth T; Rosenwald A; Staudt LM; Eilers M; Baran-Marszak F; Fagard R; Feuillard J; Laux G; Bornkamm GW
    Int J Cancer; 2007 Apr; 120(7):1387-95. PubMed ID: 17211884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA class II antigen presentation by prostate cancer cells.
    Younger AR; Amria S; Jeffrey WA; Mahdy AE; Goldstein OG; Norris JS; Haque A
    Prostate Cancer Prostatic Dis; 2008; 11(4):334-41. PubMed ID: 17938645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma cell necrosis facilitates transfer of specific sets of antigens onto MHC class II molecules of dendritic cells.
    Röhn TA; Schadendorf D; Sun Y; Nguyen XD; Roeder D; Langen H; Vogt AB; Kropshofer H
    Eur J Immunol; 2005 Oct; 35(10):2826-39. PubMed ID: 16163671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class I processing-defective Burkitt's lymphoma cells are recognized efficiently by CD4+ EBV-specific CTLs.
    Khanna R; Burrows SR; Thomson SA; Moss DJ; Cresswell P; Poulsen LM; Cooper L
    J Immunol; 1997 Apr; 158(8):3619-25. PubMed ID: 9103423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invariant-cognate peptide exchange restores class II dimer stability in HLA-DM mutants.
    Monji T; McCormack AL; Yates JR; Pious D
    J Immunol; 1994 Nov; 153(10):4468-77. PubMed ID: 7525705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat shock protein 90-mediated peptide-selective presentation of cytosolic tumor antigen for direct recognition of tumors by CD4(+) T cells.
    Tsuji T; Matsuzaki J; Caballero OL; Jungbluth AA; Ritter G; Odunsi K; Old LJ; Gnjatic S
    J Immunol; 2012 Apr; 188(8):3851-8. PubMed ID: 22427632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes.
    Brocke P; Armandola E; Garbi N; Hämmerling GJ
    Eur J Immunol; 2003 Feb; 33(2):411-21. PubMed ID: 12645938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma.
    Rousset F; Malefijt RW; Slierendregt B; Aubry JP; Bonnefoy JY; Defrance T; Banchereau J; de Vries JE
    J Immunol; 1988 Apr; 140(8):2625-32. PubMed ID: 2965726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
    Ramachandra L; Kovats S; Eastman S; Rudensky AY
    J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes.
    Kropshofer H; Spindeldreher S; Röhn TA; Platania N; Grygar C; Daniel N; Wölpl A; Langen H; Horejsi V; Vogt AB
    Nat Immunol; 2002 Jan; 3(1):61-8. PubMed ID: 11743588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of HLA-DM transfection on hen egg lysozyme presentation by T2.Ak cells.
    Albert LJ; Ghumman B; Watts TH
    J Immunol; 1996 Sep; 157(6):2247-55. PubMed ID: 8805621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the signaling function of MHC class II molecules during antigen presentation by B cells.
    St Pierre Y; Watts TH
    J Immunol; 1991 Nov; 147(9):2875-82. PubMed ID: 1680921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell phenotype dependent expression of MHC class I antigens in Burkitt's lymphoma cell lines.
    Masucci MG; Klein E
    Semin Cancer Biol; 1991 Feb; 2(1):63-71. PubMed ID: 1655115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LAMP-2C Inhibits MHC Class II Presentation of Cytoplasmic Antigens by Disrupting Chaperone-Mediated Autophagy.
    Pérez L; McLetchie S; Gardiner GJ; Deffit SN; Zhou D; Blum JS
    J Immunol; 2016 Mar; 196(6):2457-65. PubMed ID: 26856698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor-mediated endocytosis of antigens overcomes the requirement for HLA-DM in class II-restricted antigen presentation.
    Ma C; Blum JS
    J Immunol; 1997 Jan; 158(1):1-4. PubMed ID: 8977167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.